Adlai Nortye (ANL) Accumulated Depreciation & Amortization (2022 - 2025)

Adlai Nortye (ANL) reported Accumulated Depreciation & Amortization of $4.5 million for Q4 2025, up 22.44% year-over-year from $3.6 million in Q4 2024, and up 22.44% on a QoQ basis from $3.6 million in Q4 2024.

Adlai Nortye (ANL) has 4 years of Accumulated Depreciation & Amortization data on file, last reported at $4.5 million in Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 22.44% year-over-year to $4.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.5 million (up 22.44% YoY) and the FY2025 annual result came in at $4.5 million, up 22.44% from the prior year.
  • Accumulated Depreciation & Amortization grew to $4.5 million in Q4 2025 per ANL's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $4.5 million in Q4 2025 and bottomed at $2.8 million in Q4 2022.
  • The 4-year median for Accumulated Depreciation & Amortization is $3.8 million (2023), against an average of $3.7 million.
  • The widest annual swing landed in 2023, when Accumulated Depreciation & Amortization jumped 39.36%; it then dropped 7.78% in 2024.
  • Tracing ANL's Accumulated Depreciation & Amortization over 4 years: stood at $2.8 million in 2022, then soared by 39.36% to $3.9 million in 2023, then dropped by 7.78% to $3.6 million in 2024, then climbed by 22.44% to $4.5 million in 2025.
  • Per Business Quant, the three latest ANL Accumulated Depreciation & Amortization figures stand at $4.5 million (Q4 2025), $3.6 million (Q4 2024), and $3.9 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn
8 Evaxion A 65.44 Bn 65.42 Bn -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn
10 Adlai Nortye 23,840.00 -8.03 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 4.45 Mn
Dec 31, 2025 4.45 Mn
Dec 31, 2024 3.64 Mn
Dec 31, 2024 3.64 Mn
Dec 31, 2023 3.94 Mn
Dec 31, 2023 3.94 Mn
Dec 31, 2022 2.83 Mn
Dec 31, 2022 2.83 Mn